Human placenta-derived cell line (JEG-3): Control vs. valproic acid(VPA)-treated
Ontology highlight
ABSTRACT: Transcriptional profiling of human placenta-derived JEG-3 cell line comparing vehicle control with 7.38 mM of valproic acid(VPA)-treated JEG-3 cells for 48 hr. 7.38 mM valproic acid(VPA) induced the 30% inhibiotion of JEG-3 cell proliferation, G1 phase cell cycle arrest and the reduction of cell size. The Goal was to analyze the mechanism of valproic acid-induced adverse effects in placental cells.
ORGANISM(S): Homo sapiens
PROVIDER: GSE41441 | GEO | 2012/10/11
SECONDARY ACCESSION(S): PRJNA176966
REPOSITORIES: GEO
ACCESS DATA